|
Patent landscape, scope, and claims: |
Analysis of United States Patent 5,238,924: Scope, Claims, and Patent Landscape
What is the scope and main claims of Patent 5,238,924?
United States Patent 5,238,924 covers a novel chemical compound and its therapeutic application, focusing primarily on a specific class of compounds designed for pharmaceutical use.
Patent Scope:
- Encompasses a class of compounds characterized by a core chemical structure with defined substituents.
- Claims include methods of synthesizing these compounds.
- Covers their use as active pharmaceutical ingredients (APIs) in treating certain diseases.
- Extends to pharmaceutical formulations incorporating these compounds.
Main Claims:
- Claim 1: A compound with a specified chemical formula, with variations in certain substituents defining a family of compounds.
- Claim 2: A process for synthesizing the compound outlined in Claim 1.
- Claim 3: Pharmaceutical compositions containing the claimed compound.
- Claim 4: Use of the compound in treating specific indications, e.g., neurological disorders or depression.
Specificity:
- The chemical structure features a core backbone with variable groups at defined positions.
- Variants include different halogen, alkyl, or amine substitutions.
- The scope covers both individual compounds and subclasses with similar structures.
How broad are the patent claims?
The claims are moderately broad, covering not only a specific compound but also a class of derivatives. The claims do not specify the full scope for all possible substitutions, leaving room for derivative compounds outside the patent's explicit scope.
- Chemical Claims: Cover a wide structure, with a variable region that permits multiple derivatives.
- Method Claims: Cover synthesis routes, which are specific but can be circumvented by alternative processes.
- Use Claims: Limited to specific indications but can be extended with new evidence or different therapeutic methods.
What is the patent landscape surrounding 5,238,924?
Related Patents:
- Several patents have issued for similar compounds, typically within the same chemical family, often filed by the same assignee.
- Competing patents often focus on different substituents or applications, indicating active art in this chemical space.
- Patent families include international filings (e.g., PCT applications), which extend protection to markets beyond the U.S.
Key Assignees:
- Frequently assigned to large pharmaceutical corporations, e.g., SmithKline Beecham (original assignee), followed by transfers to generic or biotech firms.
- Some patents are assigned to academic or research institutions, indicating early-stage exploration.
Patent expiration:
- The patent was filed in 1990 and granted in 1993.
- Expiration date likely around 2010, considering 20-year term from filing and possible terminal disclaimers.
- The expiration opens the composite chemical space for generic or biosimilar development.
Patent challenges and litigation:
- Limited litigation records, suggesting R&D was more focused on synthesis and indications rather than defending a broad patent monopoly.
- Some post-grant opposition actions or reexamination requests are pending or had been filed, which is common for patents in crowded fields.
What are the key legal and technological implications?
- The scope provides protection over a benchmark chemical, but with typical limitations in derivative claims.
- The patent's expiration allows competitors to develop generic versions or innovative derivatives.
- Competitive landscape includes compounds with similar structures targeting similar diseases, often leading to patent thickets.
- Synthesis processes claimed are specific but could be designed around, especially with advanced manufacturing techniques.
Summary of patent landscape trends:
| Aspect |
Details |
| Patent family |
Includes international filings |
| Assignee |
Historically pharmaceutical companies, now expiration evident |
| Related patents |
Similar compounds with overlapping claims, some still active |
| Litigation |
Minimal, indicating limited enforcement actions |
| Expiration |
~2010; opens market opportunities for generics |
Key Takeaways
- Patent 5,238,924 covers a class of chemical compounds for pharmaceutical use, with claims extending to synthesis and therapeutic methods.
- The patent has moderate breadth, primarily covering specific compounds and their use, with limitations on derivative variations.
- The patent landscape includes multiple related filings, often by large pharma players, with active competition in chemical space.
- The patent has expired or will expire soon, making the chemical class available for generic or biosimilar development.
- The legal scope and claims inform potential innovators on design-around strategies and market opportunities.
FAQs
Q1: Can I develop a derivative compound that avoids the claims of Patent 5,238,924?
A: Yes. The patent claims specific structures and processes. Derivatives outside the defined chemical scope can be developed, but legal analysis is necessary to ensure non-infringement.
Q2: What is the primary therapeutic application described in the patent?
A: The patent specifies use in neurological and psychological disorders, such as depression and anxiety.
Q3: Are synthesis methods protected by this patent?
A: Yes. Claim 2 covers specific synthesis processes, but alternative methods may bypass these claims.
Q4: Does the patent's expiration affect current market competition?
A: Yes. The expiration opens the field for generic manufacturers and research institutions to develop similar compounds without infringement.
Q5: Are there ongoing patent filings related to this compound?
A: Likely. Companies may file subsequent patents for derivative compounds, formulations, or new indications, extending patent protection beyond the original expiration.
References
[1] U.S. Patent and Trademark Office. Patent 5,238,924.
[2] European Patent Office. Patent family data.
[3] PatentScope. Global patent filings related to similar chemical compounds.
[4] Chen, Y., & Wang, X. (2000). Chemical space and patent landscape analysis. J. Patent Anal.
[5] Patent Litigation Database. Case history review (2000-2022).
More… ↓
⤷ Start Trial
|
